1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing & Forecasting
2.3.1. Market Size Estimation Approach
2.3.1.1 Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth forecast Approach
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Infectious and Chronic Diseases
4.2.2. Rising Adoption of Technical Advancements to Enhance the Quality of POC Diagnostics
4.2.3. Development of CLIA-waived POC Tests
4.2.4. Growing Number of In-house Hospital Laboratories Opting for POC Diagnostic Technologies
4.3. Restraints
4.3.1. Limited Reimbursement Policies
4.3.2. Cost Constraints
4.4. Opportunity
4.4.1. Healthcare Professionals’ Increasing Preference for POC Tests Over Other Lab Tests
4.4.2. Growing Advanced Healthcare Infrastructure Across European Countries
4.5. Challenges
4.5.1. Lack of Awareness Regarding the Use of POC Devices
4.6. Industry and Technology Trends
4.7. Pricing Analysis
4.8. Regulatory Analysis
5. Europe Point-of-Care Diagnostics Market Assessment, by Offering
5.1. Overview
5.2. Consumables
5.3. Instruments
5.4. Software and Services
6. Europe Point-of-Care Diagnostics Market Assessment, by Platform
6.1. Overview
6.2. Lateral Flow Assays
6.3. Molecular Diagnostics
6.4. Other Platforms
7. Europe Point-of-Care Diagnostics Market Assessment, by Applications
7.1. Overview
7.2. Blood Glucose Monitoring
7.3. Infectious Disease Testing
7.3.1. Parasitic Infections Testing
7.3.2. Blood-borne Infections Testing
7.3.2.1. Hepatitis
7.3.2.2. HIV
7.3.2.3. Other Blood-borne Infections Testing
7.3.3. Respiratory Infections Testing
7.3.3.1. Influenza
7.3.3.2. Pneumonia
7.3.3.3. Tuberculosis (TB)
7.3.3.4. COVID-19 Testing
7.3.3.5. Other Respiratory Infections Testing
7.3.4. Healthcare-associated Infections (HAI) Testing
7.3.5. Gastrointestinal Infections Testing
7.3.5.1. Salmonellosis
7.3.5.2. E. Coli Infections
7.3.5.3. Other GI Infections Testing
7.3.6. Other Infectious Diseases Testing
7.4. Tumor/Cancer Markers Testing
7.5. Pregnancy And Fertility Testing
7.5.1. Pregnancy Testing
7.5.2. Fertility Testing
7.6. Cardiac Marker/Cardiac Metabolism Testing
7.7. Cholesterol/Lipid Profile Testing
7.8. Coagulation Testing
7.8.1. Prothrombin Time (PT/INR) Testing
7.8.2. Activated Clotting Time (ACT/APTT) Testing
7.8.3. Other Coagulation Testing
7.9. Hematology
7.10. Drugs of Abuse Testing
7.11. Urinalysis
7.12. Other POC Diagnostic Testing
8. Europe Point-of-Care Diagnostics Market Assessment, by Sample Type
8.1. Overview
8.2. Blood Sample
8.3. Nasopharyngeal Swab
8.4. Urine Sample
8.5. Saliva Sample
8.6. Other Sample Types
9. Europe Point-of-Care Diagnostics Market Assessment, by End User
9.1. Overview
9.2. Hospitals
9.3. Home Care/Self-testing
9.4. Physician Offices & Ambulatory Care Settings
9.5. Diagnostic Laboratories
9.6. Other End Users
10. Europe Point-of-Care Diagnostics Market Assessment, by Geography
10.1. Overview
10.2. Germany
10.3. France
10.4. U.K.
10.5. Italy
10.6. Spain
10.7. Switzerland
10.8. Austria
10.9. Netherlands
10.10. Rest of Europe
11. Competitive Analysis
11.1 Overview
11.2 Key Growth Strategies
11.3 Competitive Benchmarking
11.4 Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis, by the Key Player/Key Market Ranking, 2022
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Abbott Laboratories
12.2. F. Hoffmann-La Roche Ltd
12.3. Siemens Healthineers AG
12.4. Danaher Corporation
12.5. Thermo Fisher Scientific Inc.
12.6. Becton, Dickinson and Company (BD)
12.7. bioMérieux S.A.
12.8. QuidelOrtho Corporation
12.9. EKF Diagnostics Holdings plc
12.10. Sekisui Diagnostics, LLC.
12.11 Trinity Biotech plc
12.12. Chembio Diagnostics, Inc.
12.13. Werfen
12.14. Nova Biomedical
12.15. Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Europe Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 2 Europe Point-of-Care Diagnostics Consumables Market, by Country, 2021–2030 (USD Million)
Table 3 Europe Point-of-Care Diagnostics Instruments Market, by Country, 2021–2030 (USD Million)
Table 4 Europe Point-of-Care Diagnostics Market for Software and Services, by Country, 2021–2030 (USD Million)
Table 5 Europe Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 6 Europe Point-of-Care Diagnostics Market for Lateral Flow Assays, by Country, 2021–2030 (USD Million)
Table 7 Europe Point-of-Care Diagnostics Market for Molecular Diagnostics, by Country, 2021–2030 (USD Million)
Table 8 Europe Point-of-Care Diagnostics Market for Other Platforms, by Country, 2021–2030 (USD Million)
Table 9 Europe Point-of-Care Diagnostics Market, by Application, 2021–2030
Table 10 Europe Point-of-Care Diagnostics Market for Blood Glucose Monitoring, by Country, 2021–2030 (USD Million)
Table 11 Europe Point-of-Care Diagnostics Market for Infectious Diseases Testing, by Type, 2021–2030 (USD Million)
Table 12 Europe Point-of-Care Diagnostics Market for Infectious Diseases Testing, by Country, 2021–2030 (USD Million)
Table 13 Europe Point-of-Care Diagnostics Market for Parasitic Infections Testing, by Country, 2021–2030 (USD Million)
Table 14 Europe Point-of-Care Diagnostics Market for Blood-borne Infections Testing, by Type, 2021–2030 (USD Million)
Table 15 Europe Point-of-Care Diagnostics Market for Blood-borne Infections Testing, by Country, 2021–2030 (USD Million)
Table 16 Europe Point-of-Care Diagnostics Market for Hepatitis, by Country, 2021–2030 (USD Million)
Table 17 Europe Point-of-Care Diagnostics Market for HIV, by Country, 2021–2030 (USD Million)
Table 18 Europe Point-of-Care Diagnostics Market for Other Blood-borne Infections, by Country, 2021–2030 (USD Million)
Table 19 Europe Point-of-Care Diagnostics Market for Respiratory Infections Testing, by Type, 2021–2030 (USD Million)
Table 20 Europe Point-of-Care Diagnostics Market for Respiratory Infections Testing, by Country, 2021–2030 (USD Million)
Table 21 Europe Point-of-Care Diagnostics Market for Influenza, by Country, 2021–2030 (USD Million)
Table 22 Europe Point-of-Care Diagnostics Market for Pneumonia, by Country, 2021–2030 (USD Million)
Table 23 Europe Point-of-Care Diagnostics Market for Tuberculosis, by Country, 2021–2030 (USD Million)
Table 24 Europe Point-of-Care Diagnostics Market for COVID-19 Testing, by Country, 2021–2030 (USD Million)
Table 25 Europe Point-of-Care Diagnostics Market for Other Respiratory Infections Testing, by Country, 2021–2030 (USD Million)
Table 26 Europe Point-of-Care Diagnostics Market for Healthcare-associated Infection (HAI) Testing, by Country, 2021–2030 (USD Million)
Table 27 Europe Point-of-Care Diagnostics Market for Gastrointestinal Infections Testing, by Type, 2021–2030 (USD Million)
Table 28 Europe Point-of-Care Diagnostics Market for Gastrointestinal Infections Testing, by Country, 2021–2030 (USD Million)
Table 29 Europe Point-of-Care Diagnostics Market for Salmonellosis, by Country, 2021–2030 (USD Million)
Table 30 Europe Point-of-Care Diagnostics Market for E. Coli Infections, by Country, 2021–2030 (USD Million)
Table 31 Europe Point-of-Care Diagnostics Market for Other GI Infections, by Country, 2021–2030 (USD Million)
Table 32 Global Point-of-Care Diagnostics Market for Other Infectious Diseases Testing, by Country, 2021–2030 (USD Million)
Table 33 Europe Point-of-Care Diagnostics Market for Tumor/Cancer Markers Testing, by Country, 2021–2030 (USD Million)
Table 34 Europe Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing, by Type, 2021–2030 (USD Million)
Table 35 Europe Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing, by Country, 2021–2030 (USD Million)
Table 36 Europe Point-of-Care Diagnostics Market for Pregnancy Testing, by Country, 2021–2030 (USD Million)
Table 37 Europe Point-of-Care Diagnostics Market for Fertility Testing, by Country, 2021–2030 (USD Million)
Table 38 Europe Point-of-Care Diagnostics Market for Cardiac Marker/Cardiac Metabolism Testing, by Country, 2021–2030 (USD Million)
Table 39 Europe Point-of-Care Diagnostics Market for Cholesterol/Lipid Profile Testing, by Country, 2021–2030 (USD Million)
Table 40 Europe Point-of-Care Diagnostics Market for Coagulation Testing, by Type, 2021–2030 (USD Million)
Table 41 Europe Point-of-Care Diagnostics Market for Coagulation Testing, by Country, 2021–2030 (USD Million)
Table 42 Europe Point-of-Care Diagnostics Market for Prothrombin Time (PT/INR) Testing, by Country, 2021–2030 (USD Million)
Table 43 Europe Point-of-Care Diagnostics Market for Activated Clotting Time (ACT/APTT) Testing, by Country, 2021–2030 (USD Million)
Table 44 Europe Point-of-Care Diagnostics Market for Other Coagulation Testing, by Country, 2021–2030 (USD Million)
Table 45 Europe Point-of-Care Diagnostics Market for Hematology, by Country, 2021–2030 (USD Million)
Table 46 Europe Point-of-Care Diagnostics Market for Drugs of Abuse Testing, by Country, 2021–2030 (USD Million)
Table 47 Europe Point-of-Care Diagnostics Market for Urinalysis, by Country, 2021–2030 (USD Million)
Table 48 Europe Point-of-Care Diagnostics Market for Other PoC Testing, by Country, 2021–2030 (USD Million)
Table 49 Europe Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 50 Europe Point-of-Care Diagnostics Market for Blood Sample, by Country, 2021–2030 (USD Million)
Table 51 Europe Point-of-Care Diagnostics Market for Nasopharyngeal Swab, by Country, 2021–2030 (USD Million)
Table 52 Europe Point-of-Care Diagnostics Market for Urine Sample, by Country, 2021–2030 (USD Million)
Table 53 Europe Point-of-Care Diagnostics Market for Saliva Sample, by Country, 2021–2030 (USD Million)
Table 54 Europe Point-of-Care Diagnostics Market for Other Sample Types, by Country, 2021–2030 (USD Million)
Table 55 Europe Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 56 Europe Point-of-Care Diagnostics Market for Hospitals, by Country, 2021–2030 (USD Million)
Table 57 Europe Point-of-Care Diagnostics Market for Home Care/Self-testing, by Country, 2021–2030 (USD Million)
Table 58 Europe Point-of-Care Diagnostics Market for Physician Offices & Ambulatory Care Settings, by Country, 2021–2030 (USD Million)
Table 59 Europe Point-of-Care Diagnostics Market for Diagnostic Laboratories, by Country, 2021–2030 (USD Million)
Table 60 Europe Point-of-Care Diagnostics Market for Other End Users, by Country, 2021–2030 (USD Million)
Table 61 Europe Point-of-Care Diagnostics Market, by Country, 2021–2030 (USD Million)
Table 62 Europe: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 63 Europe: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 64 Europe: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 65 Europe: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 66 Europe: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 67 Europe: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 68 Europe: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 69 Europe: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 70 Europe: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 71 Europe: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030
Table 72 Europe: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 73 Germany: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 74 Germany: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 75 Germany: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 76 Germany: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 77 Germany: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 78 Germany: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 79 Germany: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 80 Germany: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 81 Germany: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 82 Germany: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 83 Germany: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 84 France: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 85 France: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 86 France: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 87 France: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 88 France: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 89 France: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 90 France: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 91 France: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 92 France: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 93 France: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 94 France: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 95 Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic
Table 96 U.K.: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 97 U.K.: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 98 U.K.: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 99 U.K.: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 100 U.K.: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 101 U.K.: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 102 U.K.: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 103 U.K.: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 104 U.K.: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 105 U.K.: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 106 U.K.: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 107 Italy: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 108 Italy: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 109 Italy: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 110 Italy: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 111 Italy: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 112 Italy: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 113 Italy: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 114 Italy: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 115 Italy: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 116 Italy: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 117 Italy: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 118 Spain: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 119 Spain: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 120 Spain: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 121 Spain: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 122 Spain: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 123 Spain: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 124 Spain: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 125 Spain: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 126 Spain: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 127 Spain: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 128 Spain: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 129 Switzerland: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 130 Switzerland: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 131 Switzerland: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 132 Switzerland: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 133 Switzerland: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 134 Switzerland: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 135 Switzerland: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 136 Switzerland: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 137 Switzerland: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 138 Switzerland: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 139 Switzerland: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 140 Austria: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 141 Austria: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 142 Austria: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 143 Austria: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 144 Austria: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 145 Austria: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 146 Austria: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 147 Austria: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 148 Austria: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 149 Austria: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 150 Austria: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 151 Netherlands: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 152 Netherlands: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 153 Netherlands: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 154 Netherlands: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 155 Netherlands: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 156 Netherlands: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 157 Netherlands: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 158 Netherlands: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 159 Netherlands: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 160 Netherlands: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 161 Netherlands: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 162 Rest of Europe: Point-of-Care Diagnostics Market, by Offering, 2021–2030 (USD Million)
Table 163 Rest of Europe: Point-of-Care Diagnostics Market, by Platform, 2021–2030 (USD Million)
Table 164 Rest of Europe: Point-of-Care Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 165 Rest of Europe: Infectious Diseases Testing Market, by Type, 2021–2030 (USD Million)
Table 166 Rest of Europe: Respiratory Infections Market, by Type, 2021–2030 (USD Million)
Table 167 Rest of Europe: Gastrointestinal Infections Market, by Type, 2021–2030 (USD Million)
Table 168 Rest of Europe: Blood-Borne Infections Market, by Type, 2021–2030 (USD Million)
Table 169 Rest of Europe: Coagulation Testing Market, by Type, 2021–2030 (USD Million)
Table 170 Rest of Europe: Pregnancy and Fertility Testing Market, by Type, 2021–2030 (USD Million)
Table 171 Rest of Europe: Point-of-Care Diagnostics Market, by Sample Type, 2021–2030 (USD Million)
Table 172 Rest of Europe: Point-of-Care Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 173 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Europe Point-of-Care Diagnostics Market, by Offering, 2024—2030 (USD Million)
Figure 8 Europe Point-of-Care Diagnostics Market, by Platform, 2024—2030 (USD Million)
Figure 9 Europe Point-of-Care Diagnostics Market, by Application, 2024—2030 (USD Million)
Figure 10 Europe Point-of-Care Diagnostics Market, by Sample Type, 2024—2030 (USD Million)
Figure 11 Europe Point-of-Care Diagnostics Market, by End User, 2024—2030 (USD Million)
Figure 12 Europe Point-of-Care Diagnostics Market, by Country, 2024—2030 (USD Million)
Figure 13 Impact Analysis: Europe Point-of-Care Diagnostics Market
Figure 14 Market Dynamics: Europe Point-of-Care Diagnostics Market
Figure 15 Europe Point-of-Care Diagnostics Market, by Offering, 2024 Vs. 2030 (USD Million)
Figure 16 Europe Point-of-Care Diagnostics Market, by Platform, 2024 Vs. 2030 (USD Million)
Figure 17 Europe Point-of-Care Diagnostics Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 18 Europe Point-of-Care Diagnostics Market, by Sample Type, 2024 Vs. 2030 (USD Million)
Figure 19 Europe Point-of-Care Diagnostics Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 20 Europe Point-of-Care Diagnostics Market, by Country, 2024 Vs. 2030 (USD Million)
Figure 21 Europe Point-of-Care Diagnostics Market, by Offering, 2024 Vs. 2030 (USD Million)
Figure 22 Europe Point-of-Care Diagnostics Market, by Platform, 2024 Vs. 2030 (USD Million)
Figure 23 Europe Point-of-Care Diagnostics Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 24 Europe Point-of-Care Diagnostics Market, by Sample Type, 2024 Vs. 2030 (USD Million)
Figure 25 Europe Point-of-Care Diagnostics Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 26 Europe Point-of-Care Diagnostics Market, by Country, 2024 Vs. 2030 (USD Million)
Figure 27 Europe Point-of-Care Diagnostics Market Snapshot
Figure 28 Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 29 Europe Point-of-Care Diagnostics Market: Vendor Dashboard
Figure 30 Europe Point-of-Care Diagnostics Market: Competitive Benchmarking, by Type
Figure 31 Abbott laboratories: Financial Snapshot, 2022
Figure 32 F. Hoffmann-La Roche Ltd: Financial Snapshot, 2022
Figure 33 Siemens Healthineers AG: Financial Snapshot, 2022
Figure 34 Danaher Corporation: Financial Snapshot, 2022
Figure 35 Thermo Fisher Scientific Inc.: Financial Snapshot 2022
Figure 36 Becton, Dickinson and Company: Financial Snapshot, 2022
Figure 37 bioMérieux S.A.: Financial Snapshot, 2022
Figure 38 QuidelOrtho Corporation: Financial Snapshot, 2022
Figure 39 EKF Diagnostics Holdings plc: Financial Snapshot, 2022
Figure 40 Sekisui Chemical Co., Ltd.: Financial Snapshot, 2022
Figure 41 Trinity Biotech plc: Financial Snapshot, 2022
Figure 42 Chembio Diagnostics: Financial Snapshot, 2022
Figure 43 Werfen: Financial Snapshot, 2022